facebook_pixel
Equity Strategy 21 March 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
China State Construction: Profit From Affordable Housing

China State Construction: Profit From Affordable Housing

* China State Construction (CSC) is one of the largest contractors in Hong Kong and the largest contractor for affordable housing in China. CSC combines the benefits of international construction experience with access to the resources of the parent group, China State Construction and Engineering Corp, the largest contractor for buildings in China. New government policy to promote the construction […]

FIND OUT MORE

Equity Strategy 20 March 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
JPMorgan: Buy. Second Phase Of Uptrend Has Started

JPMorgan: Buy. Second Phase Of Uptrend Has Started

* The biggest U.S. banks are about to learn whether they can pay out more than $75 billion in excess capital to investors as the Federal Reserve completes stress tests of their ability to survive new economic calamities. * Wells Fargo & Co. and JPMorgan Chase & Co. would lead a 69 percent increase in dividends and stock buybacks over […]

FIND OUT MORE

Equity Strategy 20 March 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Wells Fargo: Buy. Second Phase Of Uptrend Has Started

Wells Fargo: Buy. Second Phase Of Uptrend Has Started

* The biggest U.S. banks are about to learn whether they can pay out more than $75 billion in excess capital to investors as the Federal Reserve completes stress tests of their ability to survive new economic calamities. * Wells Fargo & Co. and JPMorgan Chase & Co. would lead a 69 percent increase in dividends and stock buybacks over […]

FIND OUT MORE

Equity Strategy 18 March 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Bank Of America: Buy To Profit From Dividend Increase

Bank Of America: Buy To Profit From Dividend Increase

* The biggest U.S. banks are about to learn whether they can pay out more than $75 billion in excess capital to investors as the Federal Reserve completes stress tests of their ability to survive new economic calamities * Investors and analysts including are confident the six biggest firms will pass because of the capital cushions and experience they’ve amassed since stress […]

FIND OUT MORE

Equity Strategy 17 March 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Celldex Therapeutics: Buy. Look Beyond CDX-1135

Celldex Therapeutics: Buy. Look Beyond CDX-1135

* Brean Capital: Celldex has one of the most impressive pipelines in oncology/immunotherapy. By YE14, Celldex will initiate four trials and several ISTs. Phase 3 ACT IV enrollment is expected in mid-2014, with interim analyses likely coming in early 2015 and early 2016. The ReACT trial will be fully enrolled in late 2014 with next results expected at the […]

FIND OUT MORE